Pierangelo Renella

Dr. Pierangelo Renella


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MBMeena Bolourchi
Meena Bolourchi
PRPierangelo Renella
Pierangelo Renella
RWRaymond Wang
Raymond Wang
The prevalence of aortic root dilatation (ARD) in mucopolysaccharidosis (MPS) is not well documented. We investigated aortic root measurements in 34 MPS patients at the Children’s Hospital of Orange County (CHOC). The diagnosis, treatment status, age, gender, height, weight and aortic root parameters (aortic valve annulus (AVA), sinuses of Valsalva (SoV), and sinotubular junction (STJ)) were extracted by retrospective chart review and echocardiographic measurements. Descriptive statistics, ANOVA, and paired post-hoc t-tests were used to summarize the aortic dimensions. Exact binomial 95% confidence intervals (CIs) were constructed for ARD, defined as a z-score greater than 2 at the SoV. The patient age ranged from 3.4–25.9 years (mean 13.3 ± 6.1), the height from 0.87–1.62 meters (mean 1.24 ± 0.21), and the weight from 14.1–84.5 kg (mean 34.4 ± 18.0). The prevalence of dilation at the AVA was 41% (14/34; 95% CI: 25%–59%); at the SoV was 35% (12/34; 95% CI: 20%–54%); and at the STJ was 30% (9/30; 95% CI: 15%–49%). The highest prevalence of ARD was in MPS IVa (87.5%). There was no significant difference between mean z-scores of MPS patients who received treatment with hematopoietic stem cell transplantation (HSCT) or enzyme replacement therapy (ERT) vs. untreated MPS patients at the AVA (z = 1.9 ± 2.5 vs. z = 1.5 ± 2.4; p = 0.62), SoV (z = 1.2 ± 1.6 vs. z = 1.3 ± 2.2; p = 0.79), or STJ (z = 1.0 ± 1.8 vs. z = 1.2 ± 1.6; p = 0.83). The prevalence of ARD was 35% in our cohort of MPS I–VII patients. Thus, we recommend screening for ARD on a routine basis in this patient population.

30 August 2007 in Prenatal Diagnosis
Verified
Journal Article
Closed access
PDF file
PRPierangelo Renella
Pierangelo Renella
RCR.‐K. R. Chang
R.‐K. R. Chang
DFD. A. Ferry
D. A. Ferry
RBR. D. Bart
R. D. Bart
MSM. S. Sklansky
M. S. Sklansky

26 May 2021 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
PDF file
SDSeraina Anne Dual
Seraina Anne Dual
NMNyasha G. Maforo
Nyasha G. Maforo
DMDoff B. McElhinney
Doff B. McElhinney
APAshley Elizabeth Prosper
Ashley Elizabeth Prosper
HWHolden Wu
Holden Wu
DEDaniel Bruce Ennis
Daniel Bruce Ennis

29 September 2020 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
DRDanielle C. Pa-S Repper
Danielle C. Pa-S Repper
AAAntonio C. Arrieta
Antonio C. Arrieta
JCJason E. Cook
Jason E. Cook
PRPierangelo Renella
Pierangelo Renella
We report a case of a 15-year-old female presenting with a serious multisystemic inflammatory illness during a surge of SARS-CoV-2 (COVID-19) cases in our county. The initial clinical findings of sore throat and neck stiffness, followed by signs of sepsis, raised suspicion of Lemierre syndrome early in her hospital course. However, the presence of severe respiratory distress, multifocal pneumonia with pleural effusion on chest radiograph, acute kidney injury, and the discovery of coronary artery ectasia, pointed to the new entity “multisystem inflammatory syndrome in children (MIS-C).” Immune modulatory treatment was thus considered. However, progressive neck pain and swelling, coupled with the eventual growth of Fusobacterium necrophorum on blood culture, eventually led to the correct diagnosis of Lemierre syndrome.

24 November 2022 in Children
Verified
Journal Article
Open access
PDF file
PRPierangelo Renella
Pierangelo Renella
JLJennifer Li
Jennifer Li
APAshley Elizabeth Prosper
Ashley Elizabeth Prosper
JFJ. Paul Finn
J. Paul Finn
KNKim-Lien Nguyen
Kim-Lien Nguyen
Cardiac magnetic resonance imaging and angiography have a crucial role in the diagnostic evaluation and follow up of pediatric and adult patients with congenital heart disease. Although much of the information required of advanced imaging studies can be provided by standard gadolinium-enhanced magnetic resonance imaging, the limitations of precise bolus timing, long scan duration, complex imaging protocols, and the need to image small structures limit more widespread use of this modality. Recent experience with off-label diagnostic use of ferumoxytol has helped to mitigate some of these barriers. Approved by the U.S. FDA for intravenous treatment of anemia, ferumoxytol is an ultrasmall superparamagnetic iron oxide nanoparticle that has a long blood pool residence time and high relaxivity. Once metabolized by macrophages, the iron core is incorporated into the reticuloendothelial system. In this work, we aim to summarize the evolution of ferumoxytol-enhanced cardiovascular magnetic resonance imaging and angiography and highlight its many applications for congenital heart disease.

1 September 2021 in The Journal of Pediatrics
Verified
Journal Article
Closed access
AAAmir H. Ashrafi
Amir H. Ashrafi
WLWyman Lai
Wyman Lai
SGSharib Gaffar
Sharib Gaffar
PRPierangelo Renella
Pierangelo Renella